🌟 99% Happy customers

📦 Same-day shipping on in-stock items

Catalog Number:
38260
CAS Number:
133865-89-1
Safinamide
Purity:
≥ 98 % (HPLC)
Synonym(s):
( S )-2-[[4-[(3-fluorobenzyl)oxy]benzyl]amino]propionamide
Documents
$174.96 /25 mg
Taille
Request Bulk Quote
Product Information

Safinamide is a novel compound recognized for its multifaceted applications in the pharmaceutical industry, particularly in the treatment of Parkinson's disease. This unique molecule functions as both a monoamine oxidase inhibitor and a glutamate release modulator, making it an effective adjunct therapy for patients experiencing motor fluctuations. Its dual action not only enhances dopaminergic activity but also helps in stabilizing mood and cognitive function, offering a comprehensive approach to managing Parkinson's symptoms.

Researchers and healthcare professionals appreciate Safinamide for its favorable safety profile and its ability to improve the quality of life for patients. Its efficacy in reducing "off" time and increasing "on" time without troublesome dyskinesia sets it apart from other treatments. Moreover, ongoing studies continue to explore its potential in other neurological disorders, highlighting its versatility and promise in advancing therapeutic options. Safinamide stands out as a significant advancement in neuropharmacology, providing hope for improved patient outcomes.

Synonyms
( S )-2-[[4-[(3-fluorobenzyl)oxy]benzyl]amino]propionamide
CAS Number
133865-89-1
Purity
≥ 98 % (HPLC)
Molecular Formula
C17H19FN2O2
Molecular Weight
302.35
MDL Number
MFCD00897036
PubChem ID
11722448
Melting Point
211 - 213 °C
Appearance
Poudre blanche à presque blanche à cristal
Optical Rotation
[a] 20 D = 15 - 19 ° (C=1, AcOH)
Conditions
Conserver entre 2 et 8 °C
General Information
Synonyms
( S )-2-[[4-[(3-fluorobenzyl)oxy]benzyl]amino]propionamide
CAS Number
133865-89-1
Purity
≥ 98 % (HPLC)
Molecular Formula
C17H19FN2O2
Molecular Weight
302.35
MDL Number
MFCD00897036
PubChem ID
11722448
Melting Point
211 - 213 °C
Appearance
Poudre blanche à presque blanche à cristal
Optical Rotation
[a] 20 D = 15 - 19 ° (C=1, AcOH)
Conditions
Conserver entre 2 et 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Non
Antibiotic
Non
DEA-regulated
Non
Warnings
-
Applications

Safinamide is widely utilized in research focused on

  • Neurology: Primarily used in the treatment of Parkinson's disease, it helps manage motor symptoms and improve quality of life for patients.
  • Pharmaceutical Development: Researchers explore its dual mechanism of action, which includes both glutamate modulation and monoamine oxidase inhibition, making it a valuable candidate for developing new therapies.
  • Clinical Trials: Safinamide is often involved in clinical studies aimed at understanding its efficacy in combination therapies, providing insights into personalized medicine approaches.
  • Neuroprotection Research: Investigations into its neuroprotective properties contribute to understanding how to prevent neuronal degeneration in various neurodegenerative diseases.
  • Patient Management Strategies: Its unique profile allows healthcare providers to tailor treatment plans for individuals with complex Parkinson's disease symptoms, enhancing patient outcomes.

Citations